Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Castelli

Showing results (121-130 of 236) with videos related to

Pageof 24
Sort By:
Cancer Research|June 11, 1998
Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35)D J Loftus, P Squarcina, M B Nielsen, et al.
Tissue Antigens|July 31, 2010
Evaluation of computational methods for the reconstruction of HLA haplotypesE C Castelli, C T Mendes-Junior, L C Veiga-Castelli, et al.
HLA|February 19, 2016
Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer riskF M B Zambra, V Biolchi, C C S de Cerqueira, et al.
Human Immunology|July 25, 2016
HLA-F coding and regulatory segments variability determined by massively parallel sequencing procedures in a Brazilian population sampleThálitta Hetamaro Ayala Lima, Renato Vidal Buttura, Eduardo Antônio Donadi, et al.
Forensic Science International. Genetics|February 10, 2022
Analysis and comparison of the STR genotypes called with HipSTR, STRait Razor and toaSTR by using next generation sequencing data in a Brazilian population sampleGuilherme Valle-Silva, Tamara Soledad Frontanilla, Jesús Ayala, et al.
Cancer Research|February 2, 1999
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapyL Rivoltini, P Squarcina, D J Loftus, et al.
Human Immunology|February 22, 2026
Imputing HLA-G high-resolution alleles and regulatory haplotypes from exomes and SNP array dataRafaela Miranda Barbosa, Nayane Dos Santos Brito Silva, Diogo Meyer, et al.
Human Immunology|August 14, 2018
Genetic association between HLA-G 14-bp polymorphism and diseases: A systematic review and meta-analysisBibiana Sgorla de Almeida, Yara Costa Netto Muniz, Alice Heidrich Prompt, et al.
Genetics and Molecular Biology|August 26, 2021
An immunogenetic view of COVID-19Vitor R C Aguiar, Danillo G Augusto, Erick C Castelli, et al.
International Journal of Cancer|November 28, 2000
T cell responses in colorectal cancer patients: evidence for class II HLA-restricted recognition of shared tumor-associated antigensA J Bremers, S Andreola, E Leo, et al.
Pageof 24

Showing results (121-130 of 236) with videos related to

Sort By:
Pageof 24
Cancer Research|June 11, 1998
Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35)D J Loftus, P Squarcina, M B Nielsen, et al.
Tissue Antigens|July 31, 2010
Evaluation of computational methods for the reconstruction of HLA haplotypesE C Castelli, C T Mendes-Junior, L C Veiga-Castelli, et al.
HLA|February 19, 2016
Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer riskF M B Zambra, V Biolchi, C C S de Cerqueira, et al.
Human Immunology|July 25, 2016
HLA-F coding and regulatory segments variability determined by massively parallel sequencing procedures in a Brazilian population sampleThálitta Hetamaro Ayala Lima, Renato Vidal Buttura, Eduardo Antônio Donadi, et al.
Forensic Science International. Genetics|February 10, 2022
Analysis and comparison of the STR genotypes called with HipSTR, STRait Razor and toaSTR by using next generation sequencing data in a Brazilian population sampleGuilherme Valle-Silva, Tamara Soledad Frontanilla, Jesús Ayala, et al.
Cancer Research|February 2, 1999
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapyL Rivoltini, P Squarcina, D J Loftus, et al.
Human Immunology|February 22, 2026
Imputing HLA-G high-resolution alleles and regulatory haplotypes from exomes and SNP array dataRafaela Miranda Barbosa, Nayane Dos Santos Brito Silva, Diogo Meyer, et al.
Human Immunology|August 14, 2018
Genetic association between HLA-G 14-bp polymorphism and diseases: A systematic review and meta-analysisBibiana Sgorla de Almeida, Yara Costa Netto Muniz, Alice Heidrich Prompt, et al.
Genetics and Molecular Biology|August 26, 2021
An immunogenetic view of COVID-19Vitor R C Aguiar, Danillo G Augusto, Erick C Castelli, et al.
International Journal of Cancer|November 28, 2000
T cell responses in colorectal cancer patients: evidence for class II HLA-restricted recognition of shared tumor-associated antigensA J Bremers, S Andreola, E Leo, et al.
Pageof 24